A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)

被引：0
|
作者：
Reardon, David [1 ]
Groves, Morris [2 ]
Wen, Patrick [3 ]
Nabors, Louis [4 ]
Mikkelsen, Tom [5 ]
Rosenfeld, Steve [6 ]
Harris, Dean [7 ]
DeMarini, Douglas
Suttle, Ben [8 ]
Arumugham, Thangam [8 ]
Hodge, Jeffrey [8 ]
Lager, Joanne [8 ]
机构：
[1] Duke Univ, Durham, NC USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Univ Alabama, Birmingham, AL USA
[5] Henry Ford Hlth Syst, Detroit, MI USA
[6] Columbia Univ, New York, NY USA
[7] Royal Marsden Hosp, Surrey, England
[8] GlaxoSmithKline Inc, Durham, NC USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] Phase II trial of bevacizumab and erlotinib in recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, Sith
    Vredenburgh, James
    Rich, Jeremy
    Desjardins, Annick
    Quinn, Jennifer
    Bota, Daniela
    Goli, Krishna
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [2] Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM)
    Friedman, H. S.
    Desjardins, A.
    Vredenburgh, J. J.
    Rich, J. N.
    Sathornsumetee, S.
    Gururangan, S.
    Quinn, J. A.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM).
    Galanis, E
    Buckner, JC
    Maurer, M
    Ballman, K
    Hidalgo, M
    Kreisberg, JI
    Boni, J
    James, CDD
    Jenkins, RB
    Walsh, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 107S - 107S
  • [4] A PHASE II TRIAL OF EVEROLIMUS IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Cloughesy, Timothy
    Raizer, J.
    Drappatz, J.
    Gerena-Lewis, M.
    Rogerio, J.
    Yacoub, S.
    Desjardin, A.
    NEURO-ONCOLOGY, 2011, 13 : 42 - 43
  • [5] A PHASE II TRIAL OF VANDETANIB FOR PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Kreisl, Teri
    Burman, John A.
    Albert, Paul
    Kim, Lyndon
    Moore, Kraig
    Fine, Howard
    NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
  • [6] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Garner, William J.
    Stelno, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)
    Shih, Kent
    Patel, Manish
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Garner, William
    Steino, Anne
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2014, 16
  • [8] Phase I trial of imatinib mesylate, hydroxyurea and vatalanib for patients with recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, S.
    Rich, J. N.
    Vredenburgh, J. J.
    Desjardins, A.
    Quinn, J. A.
    Gururangan, S.
    Egorin, M. J.
    Salvado, A. J.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase I trial of gefitinib and sirolimus in adults with recurrent glioblastoma multiforme (GBM)
    Phuphanich, S.
    Rudnick, J.
    Chu, R.
    Yu, J. S.
    Black, K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
    Kreisl, Teri N.
    Smith, P.
    Iwamoto, Fabio
    Sul, Joohee
    Butman, John A.
    Fine, Howard A.
    NEURO-ONCOLOGY, 2010, 12 : 71 - 72
12345